Fan Yang; Hairong Xiong; Li Duan; Qian Li; Xin Li; Yongqin Zhou

doi:10.4143/crt.2018.638

Articles

Page Path: HOME > Cancer Res Treat > Volume 51(4); 2019 > Article

Original Article MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway: Fan Yang, MS¹, Hairong Xiong, BS^2,3, Li Duan, MS^2,3, Qian Li, BS³, Xin Li, BS¹, Yongqin Zhou, MD, PhD^2,3,4,; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2019;51(4):1420-1429.
DOI: https://doi.org/10.4143/crt.2018.638
Published online: March 4, 2019

¹The Second People's Hospital of China Three Gorges University, Yichang, China

²Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China

³Medical College of Three Gorges University, Yichang, China

⁴The Institute of Infection and Inflammation, China Three Gorges University, Yichang, China

Correspondence: Yongqin Zhou, MD, PhD The Institute of Infection and Inflammation, China Three Gorges University, 8 University Road, Yichang, Hubei Province, 443000, China
Tel: 86-7176397438 Fax: 86-7176397328 E-mail: zyjzyq@163.com

*Fan Yang and Hairong Xiong contributed equally to this work.

• Received: November 20, 2018 • Accepted: February 23, 2019

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

11,253 Views
381 Download
75 Web of Science
66 Crossref
76 Scopus

prev next

Full Article

Download PDF

Abstract
Introduction
Materials and Methods
Results
Discussion
Electronic Supplementary Material
NOTES
REFERENCES

Abstract

Purpose
MicroRNAs (miRNAs) are a group of small non-coding RNAs involved in different cancers, including lung cancer. Here, we aim to investigate the expression profiles of circulating miRNAs and their roles contributed to the progress of lung cancer.
Materials and Methods
The levels of circulating miRNA in lung cancer patients were investigated by miRNAs assay. Then we predicted the target genes of aberrantly expressing miRNAs by searching genetic databases. Based on the A549 cells transfected with miR-1246 mimics or miR-1246 inhibitor,we further measured the roles of miR-1246 involving in the epithelial-mesenchymal transition (EMT), migration and invasion capacities of lung cancer cells in vitro. Finally, we detected the effects of miR-1246 on glycogen synthase kinase-3β (GSK-3β)/β-catenin pathway by immunofluorescence and Western blot, respectively.
Results
We identified that 14 miRNAs were aberrantly expressed in the serum of lung cancer patients. Among them, miR-1246 was the most up-regulated. The cell assays indicated that miR-1246 significantly increased the migration and invasion capabilities of A549 lung cancer cells. Meanwhile, immunofluorescence analysis revealed that miR-1246 promoted EMT process of A549 cells accompanying with decreasing E-cadherin expression, while increasing vimentin and transforming growth factor β (TGF-β) expression. Furthermore, an online tool predicated that miR-1246 might bind to 3′-untranslated region of GSK-3β, which was confirmed by overexpression and knockdown of miR-1246 assays.
Conclusion
Taken together, the study illustrates that miR-1246 regulates Wnt/β-catenin pathway through targeting GSK-3β/β-catenin, which partly contributing to tumor metastasis. MiR-1246 may play an essential role in the diagnosis and therapeutic of lung cancer.
Key words: MiR-1246, Epithelial–mesenchymal transition, Metastasis, Glycogen synthase kinase 3β, β-catenin, Lung neoplasms

Introduction

Lung cancer is the leading cause of cancer-related death in the world. About 1.8 million people are diagnosed with lung cancer each year, and the 5-year survival rate ranges about 4%-17% depending on stage and regional differences [1-3]. Despite rapid progresses have been made in the field of diagnostic technology and therapeutic methods, most of lung cancer patients are still diagnosed at advanced stages with poor prognosis. To date, there are limited drugs and therapeutic interventions for the majority of patients with lung cancer. Metastasis is the main factor that results in the poor prognosis of lung cancer patients [4,5]. Thus, there is an urgent requirement to identify novel biomarkers for early diagnosis and explore therapeutic strategies that can specifically alleviate tumor burden, especially reduce metastasis, prolong survival of lung cancer patients [5-8].

Epithelial-mesenchymal transition (EMT) is a program of transforming polarized epithelial cells into cells with mesenchymal phenotypes and functions, such as losing the ability of cell-cell adhesion and the phenotypes related to epithelial cells, while increasing mesenchymal cell markers and migratory capacity, resisting to apoptosis, producing extracellular matrix components, etc. [9]. It is well known that EMT plays important roles in a variety of biological processes, for instance, embryonic development, organ formation, wound healing, and fibrosis. Recent studies in cancer have revealed that initiation of metastasis requires invasion, which is enabled by EMT, and loss of E-cadherin is considered to be a fundamental event in EMT [10,11].

MicroRNAs (miRNAs) are a group of small non-coding single-stranded RNAs with approximately 20-23 nucleotides. They are transcribed by RNA polymerase II and then cleaved sequentially by Drosha and Dicer to form miRNA. Through binding to 3' untranslated region (3'-UTR) of target mRNA, miRNAs regulate post-transcriptional expression, accounting for multiple physiological processes like proliferation, differentiation, and apoptosis [1,12].

Recently, studies have demonstrated that the miRNAs were aberrantly expressed in tumor tissue and/or blood of patients with different tumors, including lung cancer[3,13,14]. More efforts have focused on miRNA as a crucial regulator involved in Wnt/β-catenin, Notch and Hedgehog pathway, etc. [15,16]. The Wnt signaling pathway has served as a critical regulator in lung development as well as physiological and pathophysiological processes of adult lung [17,18]. β-Catenin is a key protein in Wnt/β-catenin signaling cascades, and accounts for varying activities, including embryonic development, stem cell maintenance, tumorigenesis, and metastasis. Glycogen synthase kinase-3β (GSK-3β) is a negative regulator of Wnt/β-catenin signaling pathway, which locates in the upstream of β-catenin, and inhibits its excessive activation [19]. Otsuki et al. [11] reported that suppressing GSK-3β could activate Wnt/β-catenin pathway, then promote EMT and metastasis in lung cancer. Together, these data show that aberrant expression of specific miRNAs may act as biomarkers for diagnosis, prediction of prognosis, and promising targeted therapeutic agents in lung cancer patients [14,18]. Although there are increasing studies on miRNAs and lung cancer [2,3,20], to our knowledge, the level of circulating miRNAs in clinical patients with lung cancer, and the mechanism of altered circulating miRNAs on the carcinogenesis of lung cancer have not been well demonstrated.

In the present study, we investigated the expression profile of circulating miRNAs in lung cancer patients, and then explored the roles of remarkably altered miR-1246 involving in malignancy of lung cancer cells.

Materials and Methods

1. Patients and samples

In this study, we recruited 11 primary lung cancer patients (which composed of 4 squamous carcinomas, 5 adenocarcinomas, and 2 small cell lung cancer cases) and five healthy control individuals (not affected by lung diseases or any neoplastic disorder). The peripheral blood were collected from lung cancer patients prior to therapeutic interventions (surgery resection, chemotherapy, or radiotherapy). The final diagnosis of lung cancer was confirmed by pathological examination of surgical tumor resections.

2. MiRNA assay

MiRNA expression profiles in the serum of lung cancer patients and matched controls were determined by a high-throughput real-time quantitative polymerase chain reaction (RT-qPCR) after we sent the collected sera to Wcgene Biotech Shanghai Company (Shanghai, China). Briefly, total RNAs were isolated from 250 μL serum sample with 750 μL TRIZOL LS Reagent (Invitrogen, Carlsbad, CA) and 1 μL (20 nM) synthesized internal control 1 miRNA to homogenize samples and incubated for 5 minutes at room temperature. Subsequently, 200 μL chloroform were added for separating RNA. The purified RNAs were polyadenylated through a poly(A) polymerase reaction and then reversed-transcribed into cDNA. Individual miRNAs were quantified by qPCR using gene-specific primers (10 μM) for the 36 miRNAs of interest. Detailed step-by-step protocols for RNA isolation, first-strand cDNA synthesis and qPCR are available in the Supplementary Material 1. The miRNA assay analysis was carried out as details described on the website of Wcgene (http://www.wcgene.com).

3. Cell culture and transfection

Non-small cell lung cancer (NSCLC) cell line A549 (lung adenocarcinoma) was obtained from the China Center for Type Culture Collection (CCTCC) (Wuhan, China). Cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS) (Invitrogen), 100 U/mL penicillin, and 50 μg/mL streptomycin in an incubator at 37°C under humidified atmosphere containing 5% CO₂. For overexpression of miR-1246 assay, cells were transfected with 100 pmoL of miR-1246 mimics (Gene Pharma, Shanghai, China) or negative control (NC) miRNA using Lipofectamine 2000 (Invitrogen, Thermo Scientific) according to the manufacturer’s protocol. For knockdown assay, cells were transfected with miR-1246 inhibitor or inhibitor negative control (Inh-NC).

4. Cell migration and invasion assays

A549 cells were transfected with miR-1246 mimics or NC, inhibitor, or Inh-NC for 48 hours. In the migration assay, 2×10⁴ cells suspend in 200 μL serum-free medium were added to the upper chamber of a Boyden transwell with 8 μm pores (Costar #3422, Corning Incorporated, Corning, NY). Subsequently, 500 μL medium with 10% FBS was filled into the lower chamber. After incubation for 24 hours at 37°C in a 5% CO₂ humidified incubator, cells that did not migrate through the pores and remained on the surface of upper chamber membrane were gently removed by a wet cotton wool. The cells invading the filters were fixed with 4% formaldehyde (Beyotime Biotechnology, Shanghai, China), and then stained with 0.1% crystal violet solution (Beyotime Biotechnology) for 30 minutes. For the invasion assay, the upper chamber of transwell insert was first coated with Matrigel Matrix (BD Biosciences, Franklin Lakes, NJ). Aside from incubating for 48 hours, the other procedures were similar to those in migration assay. Images were captured with light microscope (Olympus, Tokyo, Japan) and cell numbers were counted in five randomly selected fields of each insert.

5. RT-qPCR assay

RT-qPCR assay was applied to evaluate the expression level of mRNA related to the EMT program in A549 cells. Total RNA was isolated from A549 cells with Trizol reagent (Gibco, Rockville, MD), the concentration and purity of isolated RNA were assessed at 260/280 nm by a nanodrop spectrophotometer (ND-2000, Thermo Fisher Scientific, Waltham, MA). For cDNA synthesis, 1 μg RNA was reversely transcribed in a 10 μL reaction mixture, containing 1 μL PrimeScript RT enzyme mix, according to manufacturer’s instructions (TaKaRa, Otsu, Japan). Real-time PCR was conducted in 20 μL reaction system including 1 μL of cDNA, 10 μL SYBR Premix Ex Taq II (TaKaRa), 0.2 μL (10 μM) of both forward and reverse primers. The PCR cycles were as follows: 95°C/30 seconds, 40 cycles of 95°C/5 seconds, 60°C/30 seconds, and the melt-curve analysis was carried out at the end of each experiment to determine that a single product per primer pair was amplified. The amplification and analysis were performed using a StepOne Software v2.1 (ABI, Foster City, CA). All qRT-PCR reactions were run in triplicate and the relative expression levels of specific gene mRNA were calculated by using the comparative threshold method (2^−ΔΔCt). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as housekeeping gene. The primer sequences used were as follows: E-cadherin primers, forward 5′-CTGCTCTTGCTGTTTCTTCGG-3′, reverse 5′-AAGTCAAAGTCCTGGTCCTCTTCTC-3′; vimentin primers, forward 5′-CACCTTCGTGAATACCAAGACCTG-3′, reverse 5′-GAAATCCTGCTCTCCTCGCC-3′; transforming growth factor β (TGF-β) primers, forward 5′-CGCCGCCTACTACTGTGAGG-3′, reverse 5′-GATGAA-GTGGACCAGCGTCTG-3′; GAPDH primers, forward 5′-GGTAGTCTCCTAAGACTTCAA-3′, reverse 5′-CCACCCTGTTGCTGTAGCC-3′.

6. Immunofluorescence assay

A549 cells were cultured on the glass cover slips and then transfected as the above stated. After incubation, cells were fixed with 4% formaldehyde for 15 minutes at 4°C, permeabilized with 0.01% Triton X-100 for 5 minutes, and blocked with 1% bovine serum albumin for 30 minutes at room temperature. Then the prepared cells were incubated with the primary antibody GSK-3β (#12456, 1:100, Cell Signaling Technology, Danvers, MA), or β-catenin (#8814, 1:100, Cell Signaling Technology) for 24 hours at 4°C. In the next day, the cells were stained with isotype-specific secondary antibody (Alexa Fluor 594-AffiniPure donkey anti-rabbit IgG) (Jackson ImmunoResearch, West Grove, PA) for 1 hour. DAPI was used to label the nuclei. Following staining, background autofluorescence was quenched by bathing slides in 0.1% Sudan Black B Solution. The slides were mounted using Prolong Gold (Invitrogen). Sections were visualized with a A1R+ confocal microscope (Nikon Corporation, Tokyo, Japan).

7. Western blot assay

Cells were lysed in RIPA buffer with complete protease inhibitor cocktail (Sigma, St. Louis, MO). The protein was quantified using a BCA Protein Assay Kit (Shanghai ExCell Biology, Inc., Shanghai, China). A total of 50 μg protein per sample was subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and then transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA). After blocked in 5% non-fat milk in TBST (pH 7.4) for 1 hour at room temperature, each membrane was incubated with primary antibodies GSK-3β (#12456, 1:1,000, Cell Signaling Technology), β-catenin (#8814, 1:1,000, Cell Signaling Technology), and β-actin (#4970L, 1:5,000, Cell Signaling Technology) overnight at 4°C. Following incubation with the specific secondary antibodies (peroxidase-conjugated AffiniPure goat anti-rabbit lgG, 1:3,000, Wuhan KeRui Biotechnology, Wuhan, China) for 1 hour, chemiluminescence signal was detected using an electrochemiluminescence kit (Cat. G2014-1, Wuhan Servicebio Technology Co., Ltd.). The density of the immunoreactive bands was analyzed using a KODAK MI software system.

8. Statistical analysis

All data derived from at least three independent experiments were presented as mean±standard error of the mean and performed using SPSS ver. 19.0 statistical software (SPSS Inc., Chicago, IL). The p-values were analyzed by one-way ANOVA and Student’s t test. In all analyses, p < 0.05 was considered to be statistically significant.

9. Ethical statement

This study was conducted in compliance with the Declaration of Helsinki. All clinical samples were obtained from consenting individuals according to protocols approved by the Ethics Committee of the Second People's Hospital of China Three Gorges University (No. 2016007).

Results

1. MiR-1246 is up-regulated in the serum of lung cancer patients

MiRNA assay was carried out to identify the expression profiles of miRNA in the serum of lung cancer patients. The results revealed that 10 miRNAs were up-regulated (miRNA-1246, miRNA-376a-5p, miRNA-1299, miRNA-373, miRNA-21, miRNA-140-5p, miRNA-432, miRNA-520d-3p, miRNA-211, and miRNA-132-5p) and four miRNAs were down-regulated (miRNA-302b, miRNA-190b, miRNA-5p, and miRNA-505) in lung cancer patients compared to healthy control subjects (Fig. 1). The whole results of miRNA assay are available in the Supplementary Material 2. Among them, miR-1246 was the most obviously expressing alteration miRNA in the lung cancer patients. Then, we predicted the target genes of these aberrantly expressing miRNAs by searching three different miRNAs databases (http://www.targetscan.org, http://www.microrna.org, http://www.microbase.org). It indicated that these miRNAs were involved in various of biological activities (Table 1), strikingly, most of them were related to metastasis. These data suggested that circulating miRNAs in patients with lung cancer may account for tumor progression, especially for metastasis.

2. MiR-1246 increases the migration and invasion of lung cancer cells

According to the above screening results, we came to focus on activities of the highest expressing miR-1246. The abilities of cell migration and invasion are important aspects of cancer metastasis. Transwell assay is widely used to measure these activities. As shown in our study, miR-1246 mimics treatment obviously increased the migration (the left of Fig. 2A, p < 0.05) and invasion (the left of Fig. 2B, p < 0.05) of lung cancer cells. While miR-1246 inhibitor significantly abrogated these abilities compared to Inh-NC transfected group (the right of Fig. 2A and B). Together the above results demonstrated that miR-1246 promoted metastasis of lung cancer cells by increasing the migration and invasion.

3. MiR-1246 promotes EMT in A549 cells

In order to investigate the effects of miR-1246 on EMT of lung cancer cells, the expression of mRNAs related to EMT process were assessed by qRT-PCR assay. Our data depicted that the level of E-cadherin, as an epithelial marker, was decreased in A549 cells after transfected with miR-1246 mimics, whereas the expression of mesenchymal marker vimentin, and TGF-β both were increased (p < 0.05) (Fig. 3A). Conversely, A549 cells transfected with miR-1246 inhibitor resulted in an increased expression of E-cadherin, while decreased expressions of vimentin and TGF-β (Fig. 3B). Consistently, both overexpression and knockdown experiments revealed that miR-1246 promoted EMT in A549 cells accompanying with the alteration of E-cadherin, Vimentin, and TGF-β protein expression, respectively. Which indicated that miR-1246 could work as a promoter of EMT in lung cancer metastasis in vitro.

4. GSK-3β is a target of miR-1246

MiRNA is well-known to regulate the activities of target genes, accounting for the behaviors of cell. Given the up-regulation of miR-1246 in serum of patients with lung cancer, we then identified the miRNA gene loci to explore the underlying molecular mechanisms of the miR-1246 impacting on malignancy of lung cancer. By using an online target prediction algorithm mirtarbase (http://mirtarbase.mbc.nctu.edu.tw/php/search.php?opt=search_box&kw=miR-1246&sort=id&order=asc&page=2), we predicted the targets of miR-1246. Among the identified potential targets, we chose to focus on the roles of GSK-3β. First, GSK-3β/β-catenin pathway was previously known as regulating tumor progression [2]. Second, the complementary sequence of miR-1246 was found in the 3′-UTR of GSK-3β mRNA (Fig. 4A) (http://mirtarbase.mbc.nctu.edu.tw/php/detail.php?mirtid=MIRT733922), it depicted that miR-1246 could directly target the 3′-UTR of GSK-3β. In order to verify this prediction, we analyzed the roles of miR-1246 on the expression of GSK-3β by immunofluorescence and western blot assay. As shown in Fig. 4B, D, and E, overexpression of miR-1246 significantly decreased GSK-3β expression (the left of Fig. 4B and D), whereas miR-1246 inhibitor increased GSK-3β expression (the right of Fig. 4B and E), which is a negative regulator of Wnt/β-catenin signaling pathway and locates in the upstream of β-catenin. Taken together, our data suggested that miR-1246 could directly target the 3′-UTR of GSK-3β mRNA, the effect may be as an upstream target of β-catenin in regulating cell activities of lung cancer.

5. β-catenin is activated by miR-1246

Previous studies have demonstrated that β-catenin, a crucial component of Wnt/β-catenin signaling pathway, can enter into the nucleus and interact with transcription factors to regulate the expression of target gene [17]. Since Wnt/β-catenin signaling pathway is an important regulator for physiological and pathophysiological processes of adult lung, we evaluated the effect of miR-1246 on the nuclear translocation of β-catenin in A549 cells by overexpression and knockdown assay, respectively. The data from overexpression assay indicated that miR-1246 mimics could strongly elevate the level of β-catenin protein in A549 cells (the left of Fig. 4C and D). Meanwhile, miR-1246 inhibitors significantly reduced the β-catenin protein levels compared to the Inh-NC in the knockdown assay (the right of Fig. 4C and E) (p < 0.05). Therefore, miR-1246 could enhance the level of β-catenin in A549 cell.

Taken together, the above findings indicate that miR-1246 could target GSK-3β/β-catenin to regulate Wnt/β-catenin signaling pathway accounting for the progress of lung cancer cells.

Discussion

Lung cancer remains the leading cause of cancer lethal worldwide partly for lacking early diagnostic markers, and common metastasis, which is the main cause of lung cancer patients’ death [4]. MiRNAs are secreted by cells into body liquids with stable and constant levels, like in peripheral blood (serum and plasma). Since collecting peripheral blood is more easily and less invasive than obtaining the other types of tissue samples, secreted miRNAs are considered to be potential non-invasive biomarkers for diagnosing and tracking disease progression [12,13,21]. Accumulating evidences indicate that miRNA expression profiles in the serum of patient represents molecular signatures, which is not only accounting for tumorigenesis, but also involving in tumor invasion and metastasis [22,23]. However, there is limited literature concerning the levels of circulating miRNAs and further exploring their roles in the progression of lung cancer. After using a high-through miRNA assay on a small number of serum samples, we found that 14 circulating miRNAs were aberrantly expressed in lung cancer patients. Among them, miR-1246 was the most remarkably altered miRNAs in the serum of lung cancer patients. Similarly, Zhang et al. [24] identified that miR-1246 was enriched in CD166⁺ lung tumor-initiating cell (TIC, also referred as cancer stem cell [CSC]) from solid tumors relative to CD166– non-TIC in lung cancer patients. Kim et al. [25] discovered that anti-miR-1246 reduced the expressions of stemness-related and EMT-related markers which associated with characteristics of CSCs, such as cellular proliferation, tumorigenesis, colony formation, and invasiveness, etc. in NSCLC cell lines in vitro. Yuan’s group reported that extracellular miR-1246, which was one of different bio-fluids, promoted lung cancer cell proliferation and enhanced radioresistance [26]. Thus, our data imply miR-1246 may be used as a serum biomarker for lung cancer patients.

The EMT process is closely related to initiate the metastasis in many cancer patients [9,10]. Importantly, miRNAs have been shown to regulate EMT [20,25]. Therefore, in this study, we investigated whether miR-1246 alteration accounted for EMT. Here, we found that miR-1246 expression was closely related to the EMT process of lung cancer cells by gaining mesenchymal markers and losing epithelial markers. MiR-1246 could significantly decrease E-cadherin expression and increase vimentin and TGF-β expression, meanwhile, knockdown miR-1246 notably inhibited the EMT. Interestingly, the data from predicting downstream genes of those aberrantly expressed miRNAs also indicated that major of miR-1246’s downstream targets were related to EMT process (Table 1).

It is well known that miRNAs regulate target genes to perform various biological and pathological function [1]. Both GSK-3β and β-catenin are crucial regulators of Wnt/β-catenin signaling implicated in the progress of various tumors [2,17]. Since miR-1246 enhanced lung cancer cell migration and invasion (Fig. 2), we further investigated whether miR-1246 impacted on the expression of GSK-3β and β-catenin during lung cancer cell metastasis. The results derived from overexpression and knockdown assays show that miR-1246 could target the expressions of GSK-3β and β-catenin. These findings are consistent with the prior reports that miR-26a enhanced invasiveness by suppressing GSK-3β in lung cancer and octamer 4/miR-1246 signaling axis promoted Wnt/β-catenin activation in liver CSCs [2,27]. Which indicates that miR-1246 can act as a promoter of lung tumor cells metastasis partly due to down-regulating GSK-3β while up-regulating β-catenin.

Together, we provide strong evidence that miR-1246 may be exploited for the early diagnosis of lung cancer. Moreover, we demonstrated that miR-1246 enhanced EMT activity of A549 cells, a crucial process for metastasis, supporting that miR-1246 can act as a promoter of A549 metastasis. We also dissected the underlying molecular mechanism of miR-1246 involved in regulating Wnt/β-catenin signaling pathway, by directly targeting the expression of GSK-3β and β-catenin, the effect may be partly contributing to the invasion and metastasis of lung cancer. In conclusion, our data illustrated that miR-1246 may behave as a non-invasive biomarker and therapeutic target of lung cancer.

Electronic Supplementary Material

Supplementary materials are available at Cancer Research and Treatment website (https://www.e-crt.org).

Supplementary Material 1

crt-2018-638-suppl1.pdf

Supplementary Material 2

crt-2018-638-suppl2.pdf

NOTES

Conflict of interest relevant to this article was not reported.

Acknowledgements

This work was supported by Natural Science Foundation of Hubei Province (2017CFB573), Scientific Research and Development Projects of Yichang Municipality (A16-301-29, A17-301-24) and Open Foundation of Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy (Three Gorges University) (2015KZL-13, 2018KZL06).

Fig. 1.

Expression profiling of circulating miRNAs in patients with lung cancer. (A) MiRNA assay analysis of circulating miRNAs from the patients with lung cancer was presented in a heat map (11 lung cancer vs. 5 health control; the 11 lung cancer group includes 4 squamous carcinomas, 4 adenocarcinomas, and 2 small cell lung cancer cases). (B) The 14 miRNAs were differentially expressed in 11 lung cancer vs. 5 health control (p < 0.05, fold-change > 2 or < 0.5). A differentially expressed miRNA was considered if their expression levels showed with fold-changes greater than 2.0 or less than 0.5. Red and blue colors indicate increased and decreased expression, respectively.

Fig. 2.

MiR-1246 enhances the migration and invasion of A549 cells. Migration and invasion assays were performed after A549 transfected with miR-1246 mimics or negative control (NC) miRNA, miR-1246 inhibitor or inhibitor negative control (Inh-NC) for 48 hours. The cells that migrated and invasive were counted, the representative images were shown. Scale bar=100 μm. (A) The migration ability of A549 cells. (B) The invasion capacity of A549 cells. Experiments were performed at least in triplicate and data are represented as mean±standard error of mean (*p < 0.05).

Fig. 3.

MiR-1246 promotes epithelial-mesenchymal transition (EMT) in A549 cells. The mRNA expression of markers (E-cadherin, vimentin, and transforming growth factor β [TGF-β]) related to EMT were measured by real-time quantitative polymerase chain reaction (RT-qPCR) assay. A549 cells were transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC). After 48 hours, whole cell lysates were prepared and RT-qPCR assay determined the mRNA level of EMT-related markers. (A) The mRNA levels of E-cadherin, vimentin, and TGF-β in A549 cells transfected by miR-1246 mimics or NC. (B) The levels of E-cadherin, vimentin, and TGF-β mRNA in A549 cells transfected with miR-1246 inhibitor or Inh-NC. All experiments were carried out more than three times and results are expressed as mean±standard error of mean (*p < 0.05, **p < 0.01).

Fig. 4.

MiR-1246 regulates Wnt/β-catenin signaling pathway through targeting glycogen synthase kinase-3β (GSK-3β)/β-catenin. (A) GSK-3β was identified as a putative target of miR-1246 through prediction databases for bioinformatics search. Schematics showing the predicted binding site of miR-1246 in the 3' untranslated region of GSK-3β. (B-E) The protein levels of GSK-3β (B, D, E) and β-catenin (C, D, E) from A549 cells transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC) were determined by immunofluorescence and western blot assay, respectively. All the values are shown as mean±standard error of mean and pooled from three independent experiments (*p < 0.05).

Table 1.

The enriched FunRich pathway of predicted genes

Pathway	Gene (%)	p-value	lg(p-value)
CDC42 signaling events	13.547	0.007	2.145
TGF-β receptor signaling	5.843	0.009	2.029
TNF receptor signaling pathway	5.688	0.013	1.889
p53 pathway	3.619	0.036	1.447
Epithelial-to-mesenchymal transition	3.464	0.061	1.212
Canonical Wnt signaling pathway	3.309	0.003	2.503
C-Myc pathway	2.947	0.029	1.537
Regulation of nuclear β-catenin signaling	2.689	0.032	1.501

TGF-β, transforming growth factor β; TNF, tumor necrosis factor.

REFERENCES

1. Uddin A, Chakraborty S. Role of miRNAs in lung cancer. J Cell Physiol. 2018;Apr. 20[Epub]. https://doi.org/10.1002/jcp.26607Article
2. Lin G, Liu B, Meng Z, Liu Y, Li X, Wu X, et al. MiR-26a enhances invasive capacity by suppressing GSK3beta in human lung cancer cells. Exp Cell Res. 2017;352:364–74. Article PubMed
3. Jiang W, Wei K, Pan C, Li H, Cao J, Han X, et al. MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer. Cell Prolif. 2018;51:e12502Article PubMed PMC
4. Wu KL, Tsai MJ, Yang CJ, Chang WA, Hung JY, Yen CJ, et al. Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib. Lung Cancer. 2015;88:187–94. Article PubMed
5. Reck M, Popat S, Reinmuth N, De Ruysscher D, Kerr KM, Peters S, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii27–39. Article PubMed PDF
6. Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I. Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci. 2018;75:3539–51. Article PubMed PMC PDF
7. Song L, Peng L, Hua S, Li X, Ma L, Jie J, et al. miR-144-5p enhances the radiosensitivity of non-small-cell lung cancer cells via targeting ATF2. Biomed Res Int. 2018;2018:5109497.Article PubMed PMC PDF
8. Kim S, Kim TM, Kim DW, Kim S, Kim M, Ahn YO, et al. Acquired resistance of MET-amplified non-small cell lung cancer cells to the MET inhibitor capmatinib. Cancer Res Treat. 2019;51:951–62. Article PubMed PDF
9. Nowrin K, Sohal SS, Peterson G, Patel R, Walters EH. Epithelial-mesenchymal transition as a fundamental underlying pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev Respir Med. 2014;8:547–59. Article PubMed
10. Sung WJ, Kim H, Park KK. The biological role of epithelial-mesenchymal transition in lung cancer (Review). Oncol Rep. 2016;36:1199–206. Article PubMed
11. Otsuki Y, Saya H, Arima Y. Prospects for new lung cancer treatments that target EMT signaling. Dev Dyn. 2018;247:462–72. Article PubMed
12. Martinez-Rivera V, Negrete-Garcia MC, Avila-Moreno F, Ortiz-Quintero B. Secreted and tissue miRNAs as diagnosis biomarkers of malignant pleural mesothelioma. Int J Mol Sci. 2018;19:E195.Article
13. Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, et al. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 2018;9:15350–64. Article PubMed PMC
14. Li L, Sun Y, Feng M, Wang L, Liu J. Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer. Oncol Lett. 2018;15:8915–25. Article PubMed PMC
15. Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, et al. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer. Mol Carcinog. 2018;57:842–53. Article PubMed
16. Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis. Int J Cancer. 2010;126:1283–90. Article PubMed PMC
17. Skronska-Wasek W, Gosens R, Konigshoff M, Baarsma HA. WNT receptor signalling in lung physiology and pathology. Pharmacol Ther. 2018;187:150–66. Article PubMed
18. Tanaka K, Kumano K, Ueno H. Intracellular signals of lung cancer cells as possible therapeutic targets. Cancer Sci. 2015;106:489–96. Article PubMed PMC
19. Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60. Article PubMed
20. Jia Z, Zhang Y, Xu Q, Guo W, Guo A. miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells. Oncol Lett. 2018;15:7369–75. Article PubMed PMC
21. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–8. Article PubMed PMC
22. Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, et al. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. Mol Oncol. 2014;8:874–83. Article PubMed PMC
23. Ortiz-Quintero B. Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. Cell Prolif. 2016;49:281–303. Article PubMed PMC
24. Zhang WC, Chin TM, Yang H, Nga ME, Lunny DP, Lim EK, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702.Article PubMed PMC PDF
25. Kim G, An HJ, Lee MJ, Song JY, Jeong JY, Lee JH, et al. HsamiR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. Lung Cancer. 2016;91:15–22. Article PubMed
26. Yuan D, Xu J, Wang J, Pan Y, Fu J, Bai Y, et al. Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget. 2016;7:32707–22. Article PubMed PMC
27. Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, et al. Octamer 4/microRNA-1246 signaling axis drives Wnt/beta-catenin activation in liver cancer stem cells. Hepatology. 2016;64:2062–76. Article PubMed

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Apoptotic extracellular vesicles derived from hypoxia-preconditioned mesenchymal stem cells within a modified gelatine hydrogel promote osteochondral regeneration by enhancing stem cell activity and regulating immunity
Zhengang Ding, Zineng Yan, Xun Yuan, Guangzhao Tian, Jiang Wu, Liwei Fu, Han Yin, Songlin He, Chao Ning, Yazhe Zheng, Zhichao Zhang, Xiang Sui, Libo Hao, Yuting Niu, Shuyun Liu, Weimin Guo, Quanyi Guo
Journal of Nanobiotechnology.2024;[Epub] CrossRef
Small Extracellular Vesicles Derived from Helicobacter Pylori‐Infected Gastric Cancer Cells Induce Lymphangiogenesis and Lymphatic Remodeling via Transfer of miR‐1246
Chen Lu, Li Xie, Shengkui Qiu, Tianlu Jiang, Luyao Wang, Zetian Chen, Yiwen Xia, Jialun Lv, Ying Li, Bowen Li, Chao Gu, Zekuan Xu
Small.2024;[Epub] CrossRef
Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
Maliheh Entezari, Mahshid Deldar Abad Paskeh, Sima Orouei, Amirabbas Kakavand, Shamin Rezaei, Elahe Sadat Hejazi, Parya Pashootan, Naghmeh Nazdari, Alireza Tavakolpournegari, Mehrdad Hashemi, Shokooh Salimimoghadam, Sepideh Mirzaei, Afshin Taheriazam, Sae
Current Cancer Drug Targets.2024; 24(1): 94. CrossRef
Exosomal derived miR-1246 from hydroquinone-transformed cells drives S phase accumulation arrest by targeting cyclin G2 in TK6 cells
Yuting Chen, Lin Chen, Shiheng Zhu, Hui Yang, Zhongming Ye, Huanhuan Wang, Haipeng Wu, Yao Wu, Qian Sun, Xiaoshan Liu, Hairong Liang, Huanwen Tang
Chemico-Biological Interactions.2024; 387: 110809. CrossRef
Role of adhesion molecules in cancer and targeted therapy
Chunmei Fan, Fang Xiong, Shanshan Zhang, Zhaojian Gong, Qianjin Liao, Guiyuan Li, Can Guo, Wei Xiong, He Huang, Zhaoyang Zeng
Science China Life Sciences.2024; 67(5): 940. CrossRef
Wnt/β-catenin-driven EMT regulation in human cancers
Wenhua Xue, Lin Yang, Chengxin Chen, Milad Ashrafizadeh, Yu Tian, Ranran Sun
Cellular and Molecular Life Sciences.2024;[Epub] CrossRef
miR‐1246 promotes osteosarcoma cell migration via NamiRNA‐enhancer network dependent on Argonaute 2
Shuai Yang, Qingping Zou, Ying Liang, Dapeng Zhang, Lina Peng, Wei Li, Wenxuan Li, Mengxing Liu, Ying Tong, Lu Chen, Peng Xu, Zhicong Yang, Kaicheng Zhou, Jianru Xiao, Hailin Wang, Wenqiang Yu
MedComm.2024;[Epub] CrossRef
miR-1246-overexpressing exosomes improve UVB-induced photoaging by activating autophagy via suppressing GSK3β
Wei Gao, Limin Yuan, Yue Zhang, Fangzhou Huang, Chen Ai, Tianci Lv, Jiale Chen, Hui Wang, Yixin Ling, Yu-shuai Wang
Photochemical & Photobiological Sciences.2024; 23(5): 957. CrossRef
Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer
Caiyan Yin, Jianwei Yu, Gaohua Liu, Jun He, Peng Wu
Pathology - Research and Practice.2024; 257: 155315. CrossRef
Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma
Farah Ramadan, Raya Saab, Farah Ghamloush, Rita Khoueiry, Zdenko Herceg, Ludovic Gomez, Bassam Badran, Philippe Clezardin, Nader Hussein, Pascale A. Cohen, Sandra E. Ghayad
Cancers.2024; 16(9): 1652. CrossRef
Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer
Zixu Zhang, David Westover, Zhantong Tang, Yue Liu, Jinghan Sun, Yunxi Sun, Runqing Zhang, Xingyue Wang, Shihui Zhou, Nigaerayi Hesilaiti, Qi Xia, Zhenfang Du
Journal of Translational Medicine.2024;[Epub] CrossRef
A study of microRNAs as new prognostic biomarkers in anal cancer patients
Olav Dahl, Mette Pernille Myklebust
Acta Oncologica.2024; 63: 456. CrossRef
Extracellular vesicles from highly invasive melanoma subpopulations increase the invasive capacity of less invasive melanoma cells through mir-1246-mediated inhibition of CCNG2
Tim Kingreen, Stefanie Kewitz-Hempel, Christian Rohde, Gerd Hause, Cord Sunderkötter, Dennis Gerloff
Cell Communication and Signaling.2024;[Epub] CrossRef
Identification of common salivary miRNA in oral lichen planus and oral squamous cell carcinoma: systematic review and meta-analysis
Maryam Koopaie, Parisa Akhbari, Mahnaz Fatahzadeh, Sajad Kolahdooz
BMC Oral Health.2024;[Epub] CrossRef
Exosomal microRNAs in cancer metastasis: A bridge between tumor micro and macroenvironment
Mohamed J. Saadh, Amirmohammad Khalifehsoltani, Abbas Hameed Abdul Hussein, Omer Qutaiba B. Allela, Hayder Naji Sameer, Jasur Rizaev, Huda Ghassan Hameed, Ameer Hassan Idan, Fahad Alsaikhan
Pathology - Research and Practice.2024; 263: 155666. CrossRef
Research progress of lncRNA and miRNA in hepatic ischemia-reperfusion injury
Shan-Fei Zhu, Wei Yuan, Yong-Liang Du, Bai-Lin Wang
Hepatobiliary & Pancreatic Diseases International.2023; 22(1): 45. CrossRef
MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
Si-si Qi, Ying Miao, You-yu Sheng, Rui-ming Hu, Jun Zhao, Qin-ping Yang
Annals of Dermatology.2023; 35(1): 46. CrossRef
Prolonged exposure to the herbicide atrazine promotes kidney fibrosis by activating Wnt/β‐catenin signaling in rats
Taiwei Wang, Xuemiao Huang, Jian Liu, Wei Liu, Zhaoyun Yang, Kang He, Junyu Chen, Lijing Zhao
Environmental Toxicology.2023; 38(5): 1143. CrossRef
MITF Downregulation Induces Death in Human Mast Cell Leukemia Cells and Impairs IgE-Dependent Degranulation
Elizabeth Proaño-Pérez, Laia Ollé, Yanru Guo, Cristina Aparicio, Mario Guerrero, Rosa Muñoz-Cano, Margarita Martin
International Journal of Molecular Sciences.2023; 24(4): 3515. CrossRef
The ameliorative effect of CangFu Daotan Decoction on polycystic ovary syndrome of rodent model is associated with m6A methylation and Wnt/β-catenin pathway
Yuwei Zhang, Haili Zhou, Caifei Ding
Gynecological Endocrinology.2023;[Epub] CrossRef
The role of selected non-coding RNAs in the biology of non-small cell lung cancer
Kajetan Kiełbowski, Konrad Ptaszyński, Janusz Wójcik, Małgorzata Edyta Wojtyś
Advances in Medical Sciences.2023; 68(1): 121. CrossRef
Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani, Sarah Mojtabavi, Mohammad Arad Zandieh, Sadaf Gholami, Mohammad Hossein Heydargoy, Maryam Jamali Hondori, Zahra Kangarloo, Mitra Behroozaghdam, Ramin Khorrami, Mohammad Ali Sheikh Bei
European Journal of Pharmacology.2023; 951: 175781. CrossRef
Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from Costaria costata
Sijie Wei, Lihua Geng, Haoyu Yu, Jing Wang, Yang Yue, Quanbin Zhang, Ning Wu
Molecules.2023; 28(11): 4343. CrossRef
Novel shikonin derivative suppresses tumor growth and metastasis intervention of Wnt/β-catenin pathway
Hongwei Han, Zhongling Wen, Xiaohui Lai, Minkai Yang, Jiangyan Fu, Liangjie Yang, Qingqing Chen, Yudi Ma, Wencai Jie, Changyi Wang, Tongming Yin, Guihua Lu, Xiaoming Wang, Shucun Sun, Quan Zhao, Jinliang Qi, Hongyan Lin, Yonghua Yang
Process Biochemistry.2023; 132: 297. CrossRef
miR-4739 promotes epithelial-mesenchymal transition and angiogenesis in “driver gene-negative” non-small cell lung cancer via activating the Wnt/β-catenin signaling
Wenjian Cen, Qin Yan, Wenpeng Zhou, Minjie Mao, Qitao Huang, Yaobin Lin, Neng Jiang
Cellular Oncology.2023; 46(6): 1821. CrossRef
Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
Elizabeth Córdoba-Lanús, Angélica Domínguez de-Barros, Alexis Oliva, Delia Mayato, Francisca Gonzalvo, Ana Remírez-Sanz, Javier J. Zulueta, Bartolomé Celli, Ciro Casanova
International Journal of Molecular Sciences.2023; 24(15): 12437. CrossRef
MicroRNAs in idiopathic inflammatory myopathies: state-of-the-art and future perspectives
Federico Pettorossi, Michela Gasparotto, Anna Ghirardello, Chiara Franco, Giulio Ceolotto, Alessandra Giannella, Luca Iaccarino, Elisabetta Zanatta, Andrea Doria, Mariele Gatto
Current Opinion in Rheumatology.2023; 35(6): 374. CrossRef
Current landscape of miRNAs and TGF‐β signaling in lung cancer progression and therapeutic targets
Bashdar Mahmud Hussen, Safeen Jasim Saleem, Snur Rasool Abdullah, Sayran Mohamadtahr, Hazha Jamal Hidayat, Mohammed Fatih Rasul, Mohammad Taheri, Arda Kiani
Molecular and Cellular Probes.2023; 72: 101929. CrossRef
miR‐199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1
Sheng Hu, Qiang Zhou, Qiang Lu, Xi Guo, Yong Wang, Yi‐Xing Duan
The Kaohsiung Journal of Medical Sciences.2023; 39(12): 1178. CrossRef
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, Waleed Hassan Almalki, Sami I. Alzarea, Imran Kazmi, Shakir Saleem, Ruqaiyah Khan, Najla Altwaijry, Harish Dureja, Sachin Kumar Singh, Kamal Dua
International Journal of Biological Macromolecules.2023; 253: 127375. CrossRef
Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer
Jennifer Sally Samson, Venkatachalam Deepa Parvathi
Medical Oncology.2023;[Epub] CrossRef
Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer
Magdalena Niemira, Anna Erol, Agnieszka Bielska, Anna Zeller, Anna Skwarska, Karolina Chwialkowska, Mariusz Kuzmicki, Jacek Szamatowicz, Joanna Reszec, Pawel Knapp, Marcin Moniuszko, Adam Kretowski
Scientific Reports.2023;[Epub] CrossRef
MiR-1246 regulates the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth
Jingyan Li, Zhanlei Zhang, Jieting Hu, Xiaoting Wan, Wei Huang, Hong Zhang, Ningyi Jiang
Molecular and Cellular Biochemistry.2022; 477(3): 649. CrossRef
A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers
Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri, Mohammad Samadian
Frontiers in Molecular Biosciences.2022;[Epub] CrossRef
The roles of G3BP1 in human diseases (review)
Yidong Ge, Jiabei Jin, Jinyun Li, Meng Ye, Xiaofeng Jin
Gene.2022; 821: 146294. CrossRef
miRNome Profiling and Functional Analysis Reveal Involvement of hsa-miR-1246 in Colon Adenoma-Carcinoma Transition by Targeting AXIN2 and CFTR
Rokas Lukosevicius, Simonas Juzenas, Violeta Salteniene, Ugne Kulokiene, Justina Arstikyte, Georg Hemmrich-Stanisak, Andre Franke, Alexander Link, Paulius Ruzgys, Saulius Satkauskas, Henrikas Pauzas, Tadas Latkauskas, Gediminas Kiudelis, Francesc Balaguer
International Journal of Molecular Sciences.2022; 23(4): 2107. CrossRef
Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer
Teng-Fei Yin, Shi-Yu Du, Dong-Yan Zhao, Xi-Zhen Sun, Yuan-Chen Zhou, Qian-Qian Wang, Ge-Yu-Jia Zhou, Shu-Kun Yao
World Journal of Clinical Cases.2022; 10(11): 3352. CrossRef
Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases
Sherona R. Sirkisoon, Grace L. Wong, Noah R. Aguayo, Daniel L. Doheny, Dongqin Zhu, Angelina T. Regua, Austin Arrigo, Sara G. Manore, Calvin Wagner, Alexandra Thomas, Ravi Singh, Fei Xing, Guangxu Jin, Kounosuke Watabe, Hui-Wen Lo
Cancer Letters.2022; 540: 215726. CrossRef
MiR‐1246 is responsible for lung cancer cells‐derived exosomes‐mediated promoting effects on lung cancer stemness via targeting TRIM17
Zhengcheng Liu, Wei Zhao, Rusong Yang
Environmental Toxicology.2022; 37(11): 2651. CrossRef
APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
Giulia Antoniali, Emiliano Dalla, Giovanna Mangiapane, Xiaolong Zhao, Xinming Jing, Yi Cheng, Veronica De Sanctis, Dilara Ayyildiz, Silvano Piazza, Mengxia Li, Gianluca Tell
Cellular and Molecular Life Sciences.2022;[Epub] CrossRef
miR-1246 Promotes Laryngeal Squamous Cell Carcinoma Progression by Interacting with THBS1
Lifeng Wu, Na Zuo, Shuo Pan, Yue Wang, Qixue Wang, Jun Ma
Journal of Environmental Pathology, Toxicology and Oncology.2022; 41(3): 65. CrossRef
Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β
Shuo Wang, Peng Du, Yudong Cao, Jinchao Ma, Xiao Yang, Ziyi Yu, Yong Yang
Cell Death Discovery.2022;[Epub] CrossRef
Discovery and validation of circulating miRNAs for the clinical prognosis of severe dengue
Umaporn Limothai, Nattawat Jantarangsi, Natthasit Suphavejkornkij, Sasipha Tachaboon, Janejira Dinhuzen, Watchadaporn Chaisuriyong, Supachoke Trongkamolchai, Mananya Wanpaisitkul, Chatchai Chulapornsiri, Anongrat Tiawilai, Thawat Tiawilai, Terapong Tantaw
PLOS Neglected Tropical Diseases.2022; 16(10): e0010836. CrossRef
miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
Hang Yan, Shengjie Tang, Shoujun Tang, Jun Zhang, Haiyang Guo, Chao Qin, Haiyang Hu, Chuan Zhong, Li Yang, Yunhe Zhu, Haining Zhou
Frontiers in Pharmacology.2022;[Epub] CrossRef
Application of bioactive metal ions in the treatment of bone defects
Shaorong Li, Yutao Cui, He Liu, Yuhang Tian, Gan Wang, Yi Fan, Jingwei Wang, Dankai Wu, Yanbing Wang
Journal of Materials Chemistry B.2022; 10(45): 9369. CrossRef
ExoBCD: a comprehensive database for exosomal biomarker discovery in breast cancer
Xuanyi Wang, Zixuan Chai, Guizhi Pan, Youjin Hao, Bo Li, Ting Ye, Yinghong Li, Fei Long, Lixin Xia, Mingwei Liu
Briefings in Bioinformatics.2021;[Epub] CrossRef
MicroRNAs and Lung Cancer: A Review Focused on Targeted Genes
Yao-Hui Wang, Zhi-Ruo Zhu, De Tong, Rui Zhou, Kui Xiao, Ling Peng
Exploratory Research and Hypothesis in Medicine.2021; 000(000): 1. CrossRef
Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion
Mingyu Qian, Zihang Chen, Xiaofan Guo, Shaobo Wang, Zongpu Zhang, Wei Qiu, Yanhua Qi, Shouji Zhang, Jianye Xu, Rongrong Zhao, Hao Xue, Gang Li
Laboratory Investigation.2021; 101(5): 612. CrossRef
MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
Shengjie Tang, Shuangjiang Li, Tao Liu, Yiwei He, Haiyang Hu, Yunhe Zhu, Shoujun Tang, Haining Zhou
Cancer Letters.2021; 502: 71. CrossRef
CD9 Upregulation-Decreased CCL21 Secretion in Mesenchymal Stem Cells Reduces Cancer Cell Migration
Chia-Chu Hsieh, Szu-Chun Hsu, Ming Yao, Dong-Ming Huang
International Journal of Molecular Sciences.2021; 22(4): 1738. CrossRef
Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients
Eijiro Ueta, Koichiro Tsutsumi, Hironari Kato, Hiroshi Matsushita, Hidenori Shiraha, Masakuni Fujii, Kazuyuki Matsumoto, Shigeru Horiguchi, Hiroyuki Okada
Scientific Reports.2021;[Epub] CrossRef
Day 7 Embryos Change the Proteomics and Exosomal Micro-RNAs Content of Bovine Uterine Fluid: Involvement of Innate Immune Functions
Kazuya Kusama, Mohammad B. Rashid, Rasoul Kowsar, Mohamed A. Marey, Anup K. Talukder, Kentaro Nagaoka, Masayuki Shimada, Hasan Khatib, Kazuhiko Imakawa, Akio Miyamoto
Frontiers in Genetics.2021;[Epub] CrossRef
MiRNAs and Cancer: Key Link in Diagnosis and Therapy
Yu Shi, Zihao Liu, Qun Lin, Qing Luo, Yinghuan Cen, Juanmei Li, Xiaolin Fang, Chang Gong
Genes.2021; 12(8): 1289. CrossRef
Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway
Fengfeng Sun, Peng Sun, Xiaofeng Yang, Liangliang Hu, Jianguo Gao, Tao Tian
Aging.2021; 13(18): 22528. CrossRef
Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer
Xuyang Liang, Zhimei Zhang, Lu Wang, Shuxian Zhang, Ling Ren, Shouying Li, Jing Xu, Shengxiang Lv
Bioengineered.2021; 12(2): 10023. CrossRef
MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
Yue-chu Dai, Yin Pan, Ming-ming Quan, Qi Chen, Yue Pan, Yan-yun Ruan, Jian-guo Sun
Frontiers in Oncology.2021;[Epub] CrossRef
Silencing of miR-1246 Induces Cell Cycle Arrest and Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells by Promoting ZNF23 Transcription
Lu Cai, Qian Zhang, Lili Du, Feiyun Zheng
Cytogenetic and Genome Research.2021; 161(10-11): 488. CrossRef
Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo
Petro Zhupanyn, Alexander Ewe, Thomas Büch, Anastasia Malek, Phil Rademacher, Claudia Müller, Anja Reinert, Yarúa Jaimes, Achim Aigner
Journal of Controlled Release.2020; 319: 63. CrossRef
MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer
Xing-Ning Lai, Jun Li, Li-Bo Tang, Wen-Tong Chen, Lei Zhang, Li-Xia Xiong
International Journal of Molecular Sciences.2020; 21(4): 1193. CrossRef
Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p
Zequn Jiang, Yanxia Ma, Tian Tian, Yan Sun, Hao Chen, Ye Lu, Yan Wu, Haiying Jiang, Wenting Li, Li Li, Hongguang Zhou, Mianhua Wu
Journal of Ethnopharmacology.2020; 258: 112836. CrossRef
Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective
Beatrice Aramini, Valentina Masciale, Khawaja Husnain Haider
World Journal of Stem Cells.2020; 12(6): 406. CrossRef
Circulating miRNAs in Small Extracellular Vesicles Secreted by a Human Melanoma Xenograft in Mouse Brains
Loredana Guglielmi, Marta Nardella, Carla Musa, Ingrid Cifola, Manuela Porru, Beatrice Cardinali, Ilaria Iannetti, Chiara Di Pietro, Giulia Bolasco, Valentina Palmieri, Laura Vilardo, Nicolò Panini, Fabrizio Bonaventura, Massimiliano Papi, Ferdinando Scav
Cancers.2020; 12(6): 1635. CrossRef
Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer
Zhaoyan Qiu, Ning Liang, Qian Huang, Tao Sun, Hongyuan Xue, Tianyu Xie, Xinxin Wang, Qian Wang
Frontiers in Oncology.2020;[Epub] CrossRef
Circulating miR-1246 in the Progression of Chronic Obstructive Pulmonary Disease (COPD) in Patients from the BODE Cohort

Sara Cazorla-Rivero, Glorian Mura-Escorche, Francisca Gonzalvo-Hernández, Delia Mayato, Elizabeth Córdoba-Lanús, Ciro Casanova
International Journal of Chronic Obstructive Pulmonary Disease.2020; Volume 15: 2727. CrossRef
miR-1260b Activates Wnt Signaling by Targeting Secreted Frizzled-Related Protein 1 to Regulate Taxane Resistance in Lung Adenocarcinoma
Jin Ren, Deqiang Wang, Hanpeng Huang, Xiaoqin Li, Xiufen Zhuang, Jian Li
Frontiers in Oncology.2020;[Epub] CrossRef
Exosomes derived from human umbilical cord blood mesenchymal stem cells improve hepatic ischemia reperfusion injury via delivering miR-1246
Kun Xie, Lei Liu, Jiangming Chen, Fubao Liu
Cell Cycle.2019; 18(24): 3491. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway

Cancer Res Treat. 2019;51(4):1420-1429. Published online March 4, 2019

DOI: https://doi.org/10.4143/crt.2018.638

XML Download

Figure

MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway

Fig. 1. Expression profiling of circulating miRNAs in patients with lung cancer. (A) MiRNA assay analysis of circulating miRNAs from the patients with lung cancer was presented in a heat map (11 lung cancer vs. 5 health control; the 11 lung cancer group includes 4 squamous carcinomas, 4 adenocarcinomas, and 2 small cell lung cancer cases). (B) The 14 miRNAs were differentially expressed in 11 lung cancer vs. 5 health control (p < 0.05, fold-change > 2 or < 0.5). A differentially expressed miRNA was considered if their expression levels showed with fold-changes greater than 2.0 or less than 0.5. Red and blue colors indicate increased and decreased expression, respectively.

Fig. 2. MiR-1246 enhances the migration and invasion of A549 cells. Migration and invasion assays were performed after A549 transfected with miR-1246 mimics or negative control (NC) miRNA, miR-1246 inhibitor or inhibitor negative control (Inh-NC) for 48 hours. The cells that migrated and invasive were counted, the representative images were shown. Scale bar=100 μm. (A) The migration ability of A549 cells. (B) The invasion capacity of A549 cells. Experiments were performed at least in triplicate and data are represented as mean±standard error of mean (*p < 0.05).

Fig. 3. MiR-1246 promotes epithelial-mesenchymal transition (EMT) in A549 cells. The mRNA expression of markers (E-cadherin, vimentin, and transforming growth factor β [TGF-β]) related to EMT were measured by real-time quantitative polymerase chain reaction (RT-qPCR) assay. A549 cells were transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC). After 48 hours, whole cell lysates were prepared and RT-qPCR assay determined the mRNA level of EMT-related markers. (A) The mRNA levels of E-cadherin, vimentin, and TGF-β in A549 cells transfected by miR-1246 mimics or NC. (B) The levels of E-cadherin, vimentin, and TGF-β mRNA in A549 cells transfected with miR-1246 inhibitor or Inh-NC. All experiments were carried out more than three times and results are expressed as mean±standard error of mean (*p < 0.05, **p < 0.01).

Fig. 4. MiR-1246 regulates Wnt/β-catenin signaling pathway through targeting glycogen synthase kinase-3β (GSK-3β)/β-catenin. (A) GSK-3β was identified as a putative target of miR-1246 through prediction databases for bioinformatics search. Schematics showing the predicted binding site of miR-1246 in the 3' untranslated region of GSK-3β. (B-E) The protein levels of GSK-3β (B, D, E) and β-catenin (C, D, E) from A549 cells transfected with miR-1246 mimics or negative control (NC), miR-1246 inhibitor, or inhibitor negative control (Inh-NC) were determined by immunofluorescence and western blot assay, respectively. All the values are shown as mean±standard error of mean and pooled from three independent experiments (*p < 0.05).

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

MiR-1246 Promotes Metastasis and Invasion of A549 cells by Targeting GSK-3β‒Mediated Wnt/β-Catenin Pathway

Pathway	Gene (%)	p-value	lg(p-value)
CDC42 signaling events	13.547	0.007	2.145
TGF-β receptor signaling	5.843	0.009	2.029
TNF receptor signaling pathway	5.688	0.013	1.889
p53 pathway	3.619	0.036	1.447
Epithelial-to-mesenchymal transition	3.464	0.061	1.212
Canonical Wnt signaling pathway	3.309	0.003	2.503
C-Myc pathway	2.947	0.029	1.537
Regulation of nuclear β-catenin signaling	2.689	0.032	1.501

Table 1. The enriched FunRich pathway of predicted genes

TGF-β, transforming growth factor β; TNF, tumor necrosis factor.